Rx only · Capsule · Oral
Bexarotene
Bexarotene
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
79
Rx · 2026 Q1
6.6K
Units dispensed
-43%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| AvKARE | unknown | 1 | SUPPLYING |
| Upsher-Smith Laboratories, LLC | unknown | 1 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 29, 2019RECALLRecall (Class II): Bexarotene Capsules, 75 mg, 100 capsules per bottle, Rx Only, Manufactured for: Upsher-Smith Laboratories, LLC, Maple G…
Failed Dissolution Specifications — Recalling firm: Upsher Smith Laboratories, Inc. — KY, OH, NJ, LA
Pill